ArticleCureus2025
Early Pars Plana Vitrectomy and Anti-vascular Endothelial Growth Factor (VEGF) in the Management of Terson Syndrome: A Case Linked to Methicillin-Resistant Staphylococcus aureus (MRSA) Meningitis.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We present a case of Terson syndrome, characterized by intraocular hemorrhage following acute intracranial events, which poses significant diagnostic and management challenges. The patient was a 45-year-old female with Terson syndrome associated with methicillin-resistant Staphylococcus aureus (MRSA) meningitis and ventriculitis. She presented with vision loss and was found to have sub-internal limiting membrane (sub-ILM) hemorrhages and dense vitreous hemorrhages. Early pars plana vitrectomy (PPV) in the left eye yielded substantial visual improvement. In contrast, delayed intervention in the right eye following anti-vascular endothelial growth factor (VEGF) therapy showed limited recovery. Systemic stabilization was achieved through targeted intravenous antibiotics. This report underscores the critical role of early surgical intervention and multidisciplinary management in optimizing visual and systemic outcomes in complex cases of Terson syndrome. The diagnostic significance of sub-ILM hemorrhage emphasizes its role as a specific marker of severe ocular involvement, necessitating prompt recognition and treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.